Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Immunology (Orlando, Fla.)|November 5, 2003
Chemokine receptor CCR5 is not required for development of experimental autoimmune gastritisJudith Field, Aiden C J Marshall, Paul J Hertzog, et al.
Plos One|July 10, 2008
Variants of ST8SIA1 are associated with risk of developing multiple sclerosisSeema Husain, Cagri Yildirim-Toruner, Justin P Rubio, et al.
Pulmonary Pharmacology & Therapeutics|July 6, 2026
Effects of anumigilimab, an anti-G-CSF receptor mAb, after segmental LPS challenge: A Phase 1b trial in healthy volunteersJens M Hohlfeld, Meike Müller, Philipp Badorrek, et al.
Glia|February 2, 2017
The TAM receptor Tyro3 regulates myelination in the central nervous systemRainer Akkermann, Andrea Aprico, Ashwyn A Perera, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Association of plasma levels of Protein S with disease severity in multiple sclerosisGerry Zm Ma, Lauren L Giuffrida, Melissa M Gresle, et al.
Plos One|June 13, 2015
The MS Risk Allele of CD40 Is Associated with Reduced Cell-Membrane Bound Expression in Antigen Presenting Cells: Implications for Gene FunctionJudith Field, Fernando Shahijanian, Stephen Schibeci, et al.
Data in Brief|December 5, 2024
A dataset examining technical factors on fixed white blood cell single-cell RNA-seqDaniel V Brown, Agnieszka Swierczak, Yue You, et al.
Journal of Neuroscience Research|March 12, 2014
Ceruloplasmin gene-deficient mice with experimental autoimmune encephalomyelitis show attenuated early disease evolutionMelissa M Gresle, Katrin Schulz, Anna Jonas, et al.
Immunology and Cell Biology|June 14, 2024
Transcriptional network analysis of peripheral blood leukocyte subsets in multiple sclerosis identifies a pathogenic role for a cytotoxicity-associated gene network in myeloid cellsMargaret A Jordan, Melissa M Gresle, Adrian T Gemiarto, et al.
Plos One|April 7, 2010
Multiple sclerosis susceptibility-associated SNPs do not influence disease severity measures in a cohort of Australian MS patientsCathy J Jensen, Jim Stankovich, Anneke Van der Walt, et al.
Pageof 3